General Information of Drug (ID: DMK4LOH)

Drug Name
Pyrrolo[2,3-d]pyrimidine derivative 14
Synonyms PMID28705083-Compound-12
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 470.6
Logarithm of the Partition Coefficient (xlogp) 3.5
Rotatable Bond Count (rotbonds) 7
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 6
Chemical Identifiers
Formula
C27H30N6O2
IUPAC Name
(E)-N-[3-[4-amino-5-(3-methoxy-4-methylphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]phenyl]-4-(dimethylamino)-N-methylbut-2-enamide
Canonical SMILES
CC1=C(C=C(C=C1)C2=CN(C3=NC=NC(=C23)N)C4=CC(=CC=C4)N(C)C(=O)/C=C/CN(C)C)OC
InChI
InChI=1S/C27H30N6O2/c1-18-11-12-19(14-23(18)35-5)22-16-33(27-25(22)26(28)29-17-30-27)21-9-6-8-20(15-21)32(4)24(34)10-7-13-31(2)3/h6-12,14-17H,13H2,1-5H3,(H2,28,29,30)/b10-7+
InChIKey
XIEVUMXHZAXKDT-JXMROGBWSA-N
Cross-matching ID
PubChem CID
71263162
TTD ID
D00KEX

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tyrosine-protein kinase BTK (ATK) TTGM6VW BTK_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Tyrosine-protein kinase BTK (ATK) DTT BTK 3.54E-01 0.24 0.56
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors.Expert Opin Ther Pat. 2017 Dec;27(12):1305-1318.